Patent · US Active

Reprogramming of cells to a new fate

US10308912B2 · kind B2 · utility

2Cited by
8References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2016
Grant dateJun 4, 2019
Priority date
Expiry dateDec 12, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention generally provides methods and compositions for transdifferentiation of an animal cell from a first non-pluripotent cell fate to a second non-pluripotent cell fate. Also provided are methods and compositions for the transdifferentiation of an animal cell from a non-pluripotent mesodermal, endodermal, or ectodermal cell fate to a different non-pluripotent mesodermal, endodermal, or ectodermal cell fate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.